144 related articles for article (PubMed ID: 12072430)
1. Blockade of AP1 transactivation abrogates the abnormal expression of breast cancer-specific gene 1 in breast cancer cells.
Lu A; Zhang F; Gupta A; Liu J
J Biol Chem; 2002 Aug; 277(35):31364-72. PubMed ID: 12072430
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences.
Lu A; Gupta A; Li C; Ahlborn TE; Ma Y; Shi EY; Liu J
Oncogene; 2001 Aug; 20(37):5173-85. PubMed ID: 11526506
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms for abnormal expression of the human breast cancer specific gene 1 in breast cancer cells.
Lu A; Li Q; Liu J
Sci China C Life Sci; 2006 Aug; 49(4):403-8. PubMed ID: 16989287
[TBL] [Abstract][Full Text] [Related]
4. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
5. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
Duan R; Ginsburg E; Vonderhaar BK
Mol Cell Endocrinol; 2008 Jan; 281(1-2):9-18. PubMed ID: 18022314
[TBL] [Abstract][Full Text] [Related]
6. [The effect of breast cancer specific gene 1 in the prognosis of breast cancer].
Wu KJ; Weng ZY; Lin GF; Wu XR; Li FM; Zhang YC
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):294-7. PubMed ID: 15842935
[TBL] [Abstract][Full Text] [Related]
7. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
8. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes.
Li JJ; Cao Y; Young MR; Colburn NH
Mol Carcinog; 2000 Nov; 29(3):159-69. PubMed ID: 11108661
[TBL] [Abstract][Full Text] [Related]
9. [Expression of BCSG1-siRNA in tumor transplants of human breast cancer cell line in nude mice].
Shen PH; Zhang W; Zhang YH; Zhang HX; Fan QX
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):691-4. PubMed ID: 21176537
[TBL] [Abstract][Full Text] [Related]
10. BCSG1 siRNA delivered by lentiviral vector suppressed proliferation and migration of MDA-MB-231 cells.
He JS; Xie N; Yang JB; Guan H; Chen WC; Zou C; Ouyang YW; Mao YS; Luo XY; Pan Y; Fu L
Int J Mol Med; 2018 Mar; 41(3):1659-1664. PubMed ID: 29286089
[TBL] [Abstract][Full Text] [Related]
11. Ets domain transcription factor PE1 suppresses human interstitial collagenase promoter activity by antagonizing protein-DNA interactions at a critical AP1 element.
Bidder M; Loewy AP; Latifi T; Newberry EP; Ferguson G; Willis DM; Towler DA
Biochemistry; 2000 Aug; 39(30):8917-28. PubMed ID: 10913304
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1.
Gupta A; Inaba S; Wong OK; Fang G; Liu J
Oncogene; 2003 Oct; 22(48):7593-9. PubMed ID: 14576821
[TBL] [Abstract][Full Text] [Related]
13. Multiple cis-elements mediate the transcriptional activation of human fra-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells.
Adiseshaiah P; Papaiahgari SR; Vuong H; Kalvakolanu DV; Reddy SP
J Biol Chem; 2003 Nov; 278(48):47423-33. PubMed ID: 13679379
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylation of the synuclein gamma gene CpG island promotes its aberrant expression in breast carcinoma and ovarian carcinoma.
Gupta A; Godwin AK; Vanderveer L; Lu A; Liu J
Cancer Res; 2003 Feb; 63(3):664-73. PubMed ID: 12566312
[TBL] [Abstract][Full Text] [Related]
15. A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes.
Dong Z; Crawford HC; Lavrovsky V; Taub D; Watts R; Matrisian LM; Colburn NH
Mol Carcinog; 1997 Jul; 19(3):204-12. PubMed ID: 9254887
[TBL] [Abstract][Full Text] [Related]
16. BCSG1 methylation status and BCSG1 expression in breast tissues derived from Chinese women with breast cancer.
Gu YM; Tan JX; Lu XW; Ding Y; Han X; Sun YJ
Oncology; 2008; 74(1-2):61-8. PubMed ID: 18544996
[TBL] [Abstract][Full Text] [Related]
17. Calphostin C induces AP1 synthesis and AP1-dependent c-jun transactivation in normal human chondrocytes independent of protein kinase C-alpha inhibition: possible role for c-jun N-terminal kinase.
Zhang M; Miller C; He Y; Martel-Pelletier J; Pelletier JP; Di Battista JA
J Cell Biochem; 1999 Dec; 76(2):290-302. PubMed ID: 10618645
[TBL] [Abstract][Full Text] [Related]
18. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
19. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
20. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]